Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Abacavir Sulfate

02 1Abiraterone Acetate

03 1Atazanavir Sulfate

04 1Bortezomib

05 1Capecitabine

06 1Dabigatran

07 1Dasatinib

08 1Efavirenz

09 1Enzalutamide

10 1Erlotinib

11 1Gefitinib

12 1Ibrutinib

13 1Imatinib Mesylate

14 1Nilotinib Hydrochloride

15 1Nintedanib Esylate

16 1Oseltamivir phosphate

17 1Palbociclib

18 1Pazopanib Hydrochloride

19 1Pemetrexed Disodium

20 1Sorafenib

21 1Sunitinib

22 1Tenofovir Disoproxil Fumarate

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass
Acebright ensures and adherence to HSE practices. Our infrastructure for oncology APIs supports capacity of 35MTs plus annually, having line 1 (20MTs) & line 2 (15MTs) separately. Our General APIs facility has capacity of 200MTs plus annually, with line 1 (110MTs) and Line 2 (90MTs) separately.
blank

01

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

Acebright India Pharma Private Limited

Acebright ensures and adherence to HSE practices. Our infrastructure for oncology APIs supports capacity of 35MTs plus annually, having line 1 (20MTs) & line 2 (15MTs) separately. Our General APIs facility has capacity of 200MTs plus annually, with line 1 (110MTs) and Line 2 (90MTs) separately.

About the Company : Acebright ensures and adherence to HSE practices. Our infrastructure for oncology APIs supports capacity of 35MTs plus annually, having line 1 (20MTs) & line 2 (15MTs) separately. Our General AP...

blank
Acebright ensures and adherence to HSE practices. Our infrastructure for oncology APIs supports capacity of 35MTs plus annually, having line 1 (20MTs) & line 2 (15MTs) separately. Our General APIs facility has capacity of 200MTs plus annually, with line 1 (110MTs) and Line 2 (90MTs) separately.
blank

02

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

Acebright India Pharma Private Limited

Acebright ensures and adherence to HSE practices. Our infrastructure for oncology APIs supports capacity of 35MTs plus annually, having line 1 (20MTs) & line 2 (15MTs) separately. Our General APIs facility has capacity of 200MTs plus annually, with line 1 (110MTs) and Line 2 (90MTs) separately.

About the Company : Acebright ensures and adherence to HSE practices. Our infrastructure for oncology APIs supports capacity of 35MTs plus annually, having line 1 (20MTs) & line 2 (15MTs) separately. Our General AP...

blank
Acebright ensures and adherence to HSE practices. Our infrastructure for oncology APIs supports capacity of 35MTs plus annually, having line 1 (20MTs) & line 2 (15MTs) separately. Our General APIs facility has capacity of 200MTs plus annually, with line 1 (110MTs) and Line 2 (90MTs) separately.
blank

03

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

Acebright India Pharma Private Limited

Acebright ensures and adherence to HSE practices. Our infrastructure for oncology APIs supports capacity of 35MTs plus annually, having line 1 (20MTs) & line 2 (15MTs) separately. Our General APIs facility has capacity of 200MTs plus annually, with line 1 (110MTs) and Line 2 (90MTs) separately.

About the Company : Acebright ensures and adherence to HSE practices. Our infrastructure for oncology APIs supports capacity of 35MTs plus annually, having line 1 (20MTs) & line 2 (15MTs) separately. Our General AP...

blank
Acebright ensures and adherence to HSE practices. Our infrastructure for oncology APIs supports capacity of 35MTs plus annually, having line 1 (20MTs) & line 2 (15MTs) separately. Our General APIs facility has capacity of 200MTs plus annually, with line 1 (110MTs) and Line 2 (90MTs) separately.
blank

04

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

Acebright India Pharma Private Limited

Acebright ensures and adherence to HSE practices. Our infrastructure for oncology APIs supports capacity of 35MTs plus annually, having line 1 (20MTs) & line 2 (15MTs) separately. Our General APIs facility has capacity of 200MTs plus annually, with line 1 (110MTs) and Line 2 (90MTs) separately.

About the Company : Acebright ensures and adherence to HSE practices. Our infrastructure for oncology APIs supports capacity of 35MTs plus annually, having line 1 (20MTs) & line 2 (15MTs) separately. Our General AP...

blank
Acebright ensures and adherence to HSE practices. Our infrastructure for oncology APIs supports capacity of 35MTs plus annually, having line 1 (20MTs) & line 2 (15MTs) separately. Our General APIs facility has capacity of 200MTs plus annually, with line 1 (110MTs) and Line 2 (90MTs) separately.
blank

05

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

Acebright India Pharma Private Limited

Acebright ensures and adherence to HSE practices. Our infrastructure for oncology APIs supports capacity of 35MTs plus annually, having line 1 (20MTs) & line 2 (15MTs) separately. Our General APIs facility has capacity of 200MTs plus annually, with line 1 (110MTs) and Line 2 (90MTs) separately.

About the Company : Acebright ensures and adherence to HSE practices. Our infrastructure for oncology APIs supports capacity of 35MTs plus annually, having line 1 (20MTs) & line 2 (15MTs) separately. Our General AP...

blank
Acebright ensures and adherence to HSE practices. Our infrastructure for oncology APIs supports capacity of 35MTs plus annually, having line 1 (20MTs) & line 2 (15MTs) separately. Our General APIs facility has capacity of 200MTs plus annually, with line 1 (110MTs) and Line 2 (90MTs) separately.
blank

06

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

Acebright India Pharma Private Limited

Acebright ensures and adherence to HSE practices. Our infrastructure for oncology APIs supports capacity of 35MTs plus annually, having line 1 (20MTs) & line 2 (15MTs) separately. Our General APIs facility has capacity of 200MTs plus annually, with line 1 (110MTs) and Line 2 (90MTs) separately.

About the Company : Acebright ensures and adherence to HSE practices. Our infrastructure for oncology APIs supports capacity of 35MTs plus annually, having line 1 (20MTs) & line 2 (15MTs) separately. Our General AP...

blank
Acebright ensures and adherence to HSE practices. Our infrastructure for oncology APIs supports capacity of 35MTs plus annually, having line 1 (20MTs) & line 2 (15MTs) separately. Our General APIs facility has capacity of 200MTs plus annually, with line 1 (110MTs) and Line 2 (90MTs) separately.
blank

07

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

Acebright India Pharma Private Limited

Acebright ensures and adherence to HSE practices. Our infrastructure for oncology APIs supports capacity of 35MTs plus annually, having line 1 (20MTs) & line 2 (15MTs) separately. Our General APIs facility has capacity of 200MTs plus annually, with line 1 (110MTs) and Line 2 (90MTs) separately.

About the Company : Acebright ensures and adherence to HSE practices. Our infrastructure for oncology APIs supports capacity of 35MTs plus annually, having line 1 (20MTs) & line 2 (15MTs) separately. Our General AP...

blank
Acebright ensures and adherence to HSE practices. Our infrastructure for oncology APIs supports capacity of 35MTs plus annually, having line 1 (20MTs) & line 2 (15MTs) separately. Our General APIs facility has capacity of 200MTs plus annually, with line 1 (110MTs) and Line 2 (90MTs) separately.
blank

08

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

Acebright India Pharma Private Limited

Acebright ensures and adherence to HSE practices. Our infrastructure for oncology APIs supports capacity of 35MTs plus annually, having line 1 (20MTs) & line 2 (15MTs) separately. Our General APIs facility has capacity of 200MTs plus annually, with line 1 (110MTs) and Line 2 (90MTs) separately.

About the Company : Acebright ensures and adherence to HSE practices. Our infrastructure for oncology APIs supports capacity of 35MTs plus annually, having line 1 (20MTs) & line 2 (15MTs) separately. Our General AP...

blank
Acebright ensures and adherence to HSE practices. Our infrastructure for oncology APIs supports capacity of 35MTs plus annually, having line 1 (20MTs) & line 2 (15MTs) separately. Our General APIs facility has capacity of 200MTs plus annually, with line 1 (110MTs) and Line 2 (90MTs) separately.
blank

09

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

Acebright India Pharma Private Limited

Acebright ensures and adherence to HSE practices. Our infrastructure for oncology APIs supports capacity of 35MTs plus annually, having line 1 (20MTs) & line 2 (15MTs) separately. Our General APIs facility has capacity of 200MTs plus annually, with line 1 (110MTs) and Line 2 (90MTs) separately.

About the Company : Acebright ensures and adherence to HSE practices. Our infrastructure for oncology APIs supports capacity of 35MTs plus annually, having line 1 (20MTs) & line 2 (15MTs) separately. Our General AP...

blank
Acebright ensures and adherence to HSE practices. Our infrastructure for oncology APIs supports capacity of 35MTs plus annually, having line 1 (20MTs) & line 2 (15MTs) separately. Our General APIs facility has capacity of 200MTs plus annually, with line 1 (110MTs) and Line 2 (90MTs) separately.
blank

10

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

Acebright India Pharma Private Limited

Acebright ensures and adherence to HSE practices. Our infrastructure for oncology APIs supports capacity of 35MTs plus annually, having line 1 (20MTs) & line 2 (15MTs) separately. Our General APIs facility has capacity of 200MTs plus annually, with line 1 (110MTs) and Line 2 (90MTs) separately.

About the Company : Acebright ensures and adherence to HSE practices. Our infrastructure for oncology APIs supports capacity of 35MTs plus annually, having line 1 (20MTs) & line 2 (15MTs) separately. Our General AP...

blank
Contact Acebright India Pharma Private Limited and get a quotation

Acebright India Pharma Private Limited is a supplier offers 25 products (APIs, Excipients or Intermediates).

Find Capecitabine bulk with DMF, JDMF offered by Acebright India Pharma Private Limited

Find Atazanavir Sulfate bulk with DMF offered by Acebright India Pharma Private Limited

Find Dabigatran Etexilate Mesylate bulk with DMF offered by Acebright India Pharma Private Limited

Find Efavirenz bulk with DMF offered by Acebright India Pharma Private Limited

Find Erlotinib Hydrochloride bulk with DMF offered by Acebright India Pharma Private Limited

Find Imatinib Mesylate bulk with DMF offered by Acebright India Pharma Private Limited

Find Lopinavir bulk with DMF offered by Acebright India Pharma Private Limited

Find Pemetrexed Disodium bulk with DMF offered by Acebright India Pharma Private Limited

Find Tenofovir Alafenamide Fumarate bulk with DMF offered by Acebright India Pharma Private Limited

Find Tenofovir Disoproxil Fumarate bulk with DMF offered by Acebright India Pharma Private Limited

Find Abacavir Sulfate bulk offered by Acebright India Pharma Private Limited

Find Abiraterone Acetate bulk offered by Acebright India Pharma Private Limited

Find Bortezomib bulk offered by Acebright India Pharma Private Limited

Find Dasatinib bulk offered by Acebright India Pharma Private Limited

Find Enzalutamide bulk offered by Acebright India Pharma Private Limited

Find Erlotinib bulk offered by Acebright India Pharma Private Limited

Find Gefitinib bulk offered by Acebright India Pharma Private Limited

Find Ibrutinib bulk offered by Acebright India Pharma Private Limited

Find Nilotinib bulk offered by Acebright India Pharma Private Limited

Find Nintedanib Esylate bulk offered by Acebright India Pharma Private Limited

Find Oseltamivir Phosphate bulk offered by Acebright India Pharma Private Limited

Find Palbociclib bulk offered by Acebright India Pharma Private Limited

Find Pazopanib Hydrochloride bulk offered by Acebright India Pharma Private Limited

Find Sorafenib bulk offered by Acebright India Pharma Private Limited

Find Sunitinib bulk offered by Acebright India Pharma Private Limited